Martin Haluzik

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 240 publications

Real-Time Continuous Glucose Monitoring Improves Glycemic Control in the Early Postoperative Period Following Liver Transplantation: A Randomized Controlled Trial.

Real-Time Continuous Glucose Monitoring Improves Glycemic Control in the Early Postoperative Period Following Liver Transplantation: A Randomized Controlled Trial.

Journal: Diabetes technology & therapeutics

Published: August 25, 2026

Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Journal: Reviews in endocrine & metabolic disorders

Published: June 24, 2026

Assessing the efficacy, safety and utility of fully closed-loop insulin delivery compared to standard insulin therapy with a continuous glucose monitor in adults with type 2 diabetes (COYOTE study): a randomised parallel study protocol.

Assessing the efficacy, safety and utility of fully closed-loop insulin delivery compared to standard insulin therapy with a continuous glucose monitor in adults with type 2 diabetes (COYOTE study): a randomised parallel study protocol.

Journal: BMJ open

Published: May 19, 2026

Heart failure and its progression is associated with changed lymphocyte profile in epicardial adipose tissue.

Heart failure and its progression is associated with changed lymphocyte profile in epicardial adipose tissue.

Journal: Frontiers in immunology

Published: May 07, 2026

Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study.

Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study.

Journal: The lancet. Diabetes & endocrinology

Published: April 29, 2026

Impact of a durable left ventricular assist device on inflammation and cardiac remodelling in subjects with advanced heart failure.

Impact of a durable left ventricular assist device on inflammation and cardiac remodelling in subjects with advanced heart failure.

Journal: Open heart

Published: April 26, 2026

Subcutaneous glucose tracking during extreme perioperative perfusion stress: a prospective microdialysis study.

Subcutaneous glucose tracking during extreme perioperative perfusion stress: a prospective microdialysis study.

Journal: Journal of clinical monitoring and computing

Published: April 24, 2026

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

Journal: Journal of molecular and cellular cardiology plus

Published: April 23, 2026

Breaking barriers in pulmonary health of patients with metabolic diseases: senolytics and beyond.

Breaking barriers in pulmonary health of patients with metabolic diseases: senolytics and beyond.

Journal: Frontiers in aging

Published: February 17, 2026

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.

Journal: JAMA internal medicine

Published: February 02, 2026

Targeting Cellular Senescence as a Therapeutic Strategy to Attenuate Pulmonary Fibrosis Associated with Metabolic Syndrome.

Targeting Cellular Senescence as a Therapeutic Strategy to Attenuate Pulmonary Fibrosis Associated with Metabolic Syndrome.

Journal: Aging and disease

Published: January 31, 2026

Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement.

Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statement.

Journal: European journal of internal medicine

Published: January 14, 2026

Showing 1-12 of 240

Last Updated: 09/26/2026